Supermarket investors: Is it time to say hello to lower profits?

Wesfarmers Ltd (ASX:WES) and Woolworths Limited (ASX:WOW) continue to slash prices, which can't bode well for their underlying profits.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

According to reports released by Fairfax media this morning, research from Deutsche Bank shows that Australian supermarkets owned by Woolworths Limited (ASX: WOW) and Wesfarmers Ltd (ASX: WES) continue to slash prices on their private-label products in order to win over consumers.

Deutsche Bank found that premium private-label prices plunged 9% at Woolworths and 7% at Coles (owned by Wesfarmers) in the three months to the end of September. Falling private label prices often place pressure on other brands to follow suit, lest their products become unappealing to price-conscious consumers.

'Home Brand' products have declined in price fairly consistently since March 2012, compared to 'Branded' products which have grown modestly in value. While Woolworths and Coles have made the news in recent times for pressuring suppliers to lower prices in order to maintain profit margins at lower prices, prices can only be cut so far.

Woolworths currently leads Coles with a profit margin of around ~7.2% compared to Coles ~4.7%, although management and analysts both expect Woolworths' margins to decline meaningfully in the coming year.

However, with Aldi and Costco both making waves with their substantially cheaper groceries, both Woolworths AND Coles could expect to see weaker margins over time if they cut prices to compete. This raises issues with regards to the growth outlook for both businesses, which is fairly anaemic.

While their dividends are sustainable, investors will want to do their research before buying stocks that face this kind of near-term headwind.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »